NL-OMON38711撤回不适用
The effects of Transjugular Intrahepatic Portosystemic Shunt placement on von Willebrand factor levels in plasma of patients with cirrhosis and portal hypertension. - VWF-TIPS study
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patient with cirrhosis undergoing TIPS placement
- •- >=18 years of age
- •- Signed informed consent
排除标准
- •Patients with hemophilia A or von Willebrands disease
研究者
相似试验
尚未招募
不适用
Transjugular intrahepatic portosystemic shunt insertion in hepatic patients on the haemodynamicsPACTR201807337809744ational Liver Institute40
已完成
不适用
The impact of trans-jugular intrahepatic portosystemic shunts on muscle mass in chronic liver disease.portal hypertensionsarcopeniaTrans-jugular intrahepatic portosystemic shuntOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disorderscirrhosisACTRN12619000081112Department of Gastroenterology and Hepatology, Austin Health14
招募中
不适用
Influence of the transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients on sarcopeniaMuscle wasting and atrophy, not elsewhere classified, multiple sitesM62.59K74.6Other and unspecified cirrhosis of liverDRKS00024507niversitätsklinikum Freiburg100
已完成
不适用
Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary SyndromeHepatopulmonary SyndromeNCT02148536West China Hospital64
进行中（未招募）
不适用
Covered Transjugular Intrahepatic Portosystemic Stent Shunt versus Optimized medical Treatment for the Secondary Prevention of Variceal Bleeding in Cirrhosisliver cirrhosisesophageal (variceal) bleedingEUCTR2005-003557-27-DEDean of the Medical Faculty (University of Bonn)